Antagonist pharmacology of kainate- and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors

Molecular Pharmacology

Volumn 49, Issue 3, 1996, Pages 540-546

  Wilding, Timothy J ^a   Huettner, James E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 7 TRIFLUOROMETHYL 2,3 QUINOXALINEDIONE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; 6,7,8,9 TETRAHYDRO 5 NITROBENZ[G]INDOLE 2,3 DIONE 3 OXIME; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; BENZAZEPINE DERIVATIVE; GAMMA DEXTRO GLUTAMYLAMINOMETHYLSULFONIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; KYNURENIC ACID DERIVATIVE; QUINOXALINE DERIVATIVE; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL GANGLION;

ANIMALS; BINDING, COMPETITIVE; CEREBRAL CORTEX; GANGLIA, SPINAL; MEMBRANE POTENTIALS; NEURONS; QUINOXALINES; RATS; RATS, INBRED STRAINS; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID;

EID: 0029924437     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Watkins, J. C., and R. H. Evans. Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol. 21:165-204 (1981).
2. Partin, K. M., D. K. Patneau, C. A. Winters, M. L. Mayer, and A. Buonanno. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron 11:1069-1082 (1993).
3. Puchalski, R. B., J.-C. Louis, N. Brose, S. F. Traynelis, J. Egebjerg, V. Kukekov, R. J. Wenthold, S W. Rogers, F. Lin, T. Moran, J. H. Morrison, and S. F. Heinemann. Selective RNA editing and subunit assembly of native glutamate receptors. Neuron 13:131-147 (1994).
4. Boulter, J , M. Hollmann, A. O'Shea-Greenfield, M. Hartley, E. Deneris, C. Maron, and S. Heinemann. Molecular cloning and functional expression of glutamate receptor subunit genes. Science (Washington D. C.) 249:1033-1037 (1990).
5. Keinanen, K., W. Wisden, B. Sommer, P. Werner, A. Herb, T. A. Verdoorn, B. Sakmann, and P. H. Seeburg. A family of AMPA-selective glutamate receptors. Science (Washington D. C.) 249:556-560 (1990).
6. Bettler, B., J. Boulter, I. Hermans-Borgmeyer, A. O'Shea-Greenfield, E. Deneris, C. Moll, U. Borgmeyer, M. Hollmann, and S. Heinemann. Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. Neuron 5:583-595 (1990).
7. Egebjerg, J., B. Bettler, I. Hermans-Borgmeyer, and S. Heinemann. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature (Lond.) 351:745-748 (1991).
8. Sommer, B., N. Burnashev, T. A. Verdoorn, K. Keinanen, B. Sakmann, and P. H. Seeburg A glutamate receptor channel with high affinity for domoate and kainate. EMBO J. 11:1651-1656 (1992)
9. Bettler, B., J. Egebjerg, G Sharma, G. Pecht, I. Hermans-Borgmeyer, C. Moll, C. F. Stevens, and S. Heinemann. Cloning of a putative glutamate receptor: a low affinity kainate-binding subunit. Neuron 8:257-265 (1992).
10. Werner, P., M. Voigt, K. Keinanen, W. Wisden, and P. H. Seeburg. Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells. Nature (Lond.) 351:742-744 (1991).
11. Sakimura, K., T. Monta, E. Kushiya, and M. Mishina. Primary structure and expression of the γ2 subunit of the glutamate receptor channel selective for kainate. Neuron 8:267-274 (1992).
12. Herb, A., N. Burnashev, P. Werner, B. Sakmann, W. Wisden, and P. H. Seeburg. The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuron 8:775-785 (1992).
13. Nadler, J. V., B. W. Perry, and C. W. Cotman. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature (Lond.) 271; 676-677 (1978).
14. Agrawal, S. G., and R. H. Evans. The primary afferent depolarizing action of kainate in the rat. Br. J. Pharmacol. 87:345-355 (1986).
15. Huettner, J. E. Glutamate receptor channels in rat DRG neurons: activation by kainate and quisqualate and blockade of desensitization by Con A. Neuron 5:255-266 (1990)
16. Wong, L. A., and M. L. Mayer. Differential modulation by cyclothiazide and concanavalin A of desensitization at native α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors. Mol. Pharmacol. 44:504-510 (1993).
17. Spruston, N., P. Jonas, and B. Sakmann. Dendritic glutamate receptor channels in rat hippocampal CA3 and CA1 pyramidal neurons. J. Physiol. (Lond.) 482:325-352 (1995).
18. Wong, L. A., M. L. Mayer, D. E. Jane, and J. C. Watkins. Willardines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons. J. Neurosci. 14: 3881-3897 (1994).
19. Patneau, D. K., P. W. Wright, C. Winters, M. L. Mayer, and V. Gallo. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron 12:357-371 (1994).
20. Paternain, A. V., Morales, M., and Lerma, J. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron 14:185-189 (1995).
21. Wilding, T. J., and Huettner, J. E. Differential antagonism of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-beazodiazepines. Mol. Pharmacol. 47:582-587 (1995).
22. Verdoorn, T. A., T. H. Johansen, J. Drejer, and E. Ø. Nielsen. Selective block of recombinant glur6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur. J. Pharmacol. 269:43-49 (1994).
23. Huettner, J. E., and R. W. Baughman. Primary culture of identified neurons from the visual cortex of postnatal rats. J. Neurosci. 6:3044-3060 (1986).
24. Woodward, R. M., J. E. Huettner, J. Guastella, J. F. W. Keana, and E. Weber. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol. Pharmacol. 47:568-581 (1995).
25. Patneau, D. K., and M. L Mayer. Kinetic analysis of interactions between kainate and AMPA: evidence for activation of a single receptor in mouse hippocampal neurons. Neuron 6:785-798 (1991).
26. Sheardown, M. J., E. Ø. Nielsen, A. J. Hansen, P. Jacobsen, and T. Honoré. 2,3-Dihydroxy-6-nitro-7sulfamoyl-benzo(F)quinoxaune: a neuroprotectant for cerebral ischemia. Science (Washington D. C.) 247:571-574 (1990).
27. Lutfy, K., R. M. Woodward, J. F. W. Keana, and E. Weber. Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists: MK-801 and ACEA-1011. Eur. J. Pharmacol. 252:261-266 (1994).
28. Woodward, R. M., J. E. Huettner, J. Guastella, J. F. W. Keana, and E. Weber. Pharmacology of ACEA-1011: a novel systemically active ionotropic glutamate receptor antagonist J. Pharmacol. Exp. Ther., in press.
29. Davies J., and J. C. Watkins. Differentiation of kainate and quisqualate receptors in the cat spinal cord by selective antagonism with γ-D- (and L)-glutamylglycine. Brain Res. 206:172-177 (1981).
30. Zhou N., and T. N. Parks. γ-D-Glutamylaminomethyl sulfonic acid (GAMS) distinguishes subtypes of glutamate receptor in the chick cochlear nucleus (nuc. magnocellularis). Hearing Res. 60:20-26 (1992).
31. Zhou, N., L. G. Hammerland, and T. N. Parks. γ-D-Glutamylaminomethyl sulfonic acid (GAMS) distinguishes kainic acid- from AMPA-induced responses in Xenopus oocytes expressing chick brain glutamate receptors. Neuropharmacology 32:767-775 (1993).
32. Geoffroy, M., B. Lambolez, E. Audinat, B. Hamon, F. Crepel, J. Rossier, and R. T. Kado. Reduction of desensitization of a glutamate ionotropic receptor by antagonists. Mol. Pharmacol. 39:587-591 (1991).
33. Wahl, P., B. Nielsen, P. Krogsgaard-Larsen, J. J. Hansen, A. Schousboe, and R. Miledi. Stereoselective effects of AMOA on non-NMDA receptors expressed in Xenopus oocytes. J. Neurosci. Res. 33:392-397 (1992).
34. McNamara, D., E. C. R. Smith, D. O. Calligaro, P. J. O'Malley, L. A. McQuaid, and R. Diugledine. 5,7-Dichlorokynurenic acid, a potent and selective competitive antagonist of the glycine site on NMDA receptors. Neurosci. Lett. 120:17-20 (1990).
35. Baron, B. M., B. L. Harrison, F. P. Miller, I. A. McDonald, F. G. Salituro, C. J. Schmidt, S. M. Sorensen, H S. White, and M. G. Palfreyman. Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site. Mol. Pharmacol. 38: 554-561 (1990).
36. Evans, R. H., S. J. Evans, P. C. Pook, and D. C. Sunter. A comparison of excitatory amino acid antagonists acting at primary afferent C fibres and motoneurones of the isolated spinal cord of the rat. Br. J. Pharmacol. 91:531-537 (1987).
37. Pook, P., F. Brugger, N. S. Hawkins, K. C. Clark, J. C. Watkins, and R. H. Evans. A comparison of the actions of agonists and antagonists at non-NMDA receptors of C-fibres and motoneurones of the immature rat spinal cord in vitro. Br. J. Pharmacol. 108:179-184 (1993).
38. Randle, J. C. R., T. Guet, C. Bobichon, C. Moreau, P. Curutchet, B. Lambolez, L. Prado De Carvalho, A. Cordi, J. M. Lepagnol. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and of non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials. Mol. Pharmacol. 41: 337-345 (1992).
39. 3H]kainate binding. Eur. J. Pharmacol. 246:195-204 (1993).
40. Lerma, J., A. V. Paternain, J. R. Naranjo, and B. Mellström. Functional kainate-selective glutamate receptors in cultured hippocampal neurons. Proc. Natl. Acad. Sci. USA 90:11688-11692 (1993).
41. Blake, J. F., R. G. Yates, M. W. Brown, and G. L. Collingridge. 6-Cyano-7-nitroquinoxaline-2,3-dione as an excitatory amino acid antagonist in area CA1 of rat hippocampus. Br. J. Pharmacol. 97:71-76 (1988).
42. Fletcher, E. J., D. Martin, J. A. Aram, D. Lodge, and T. Honoré. Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro. Br. J. Pharmacol. 95:585-597 (1988).
43. Verdoorn, T. A., N. W. Kleckner, and R. Dingledine. N-Methyl-D-aspartate/ glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology Mol. Pharmacol. 35:360-368 (1988).
44. Honoré, T., S. N. Davies, J. Drejer, E. J. Fletcher, P. Jacobsen, D. Lodge, F. E. Nielsen Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science (Washington D. C.) 241:701-703 (1988).
45. Ruano, D., B. Lambolez, J. Rossier, A. V. Paternain, and J. Lerma. Kainate receptor subunits expressed in single cultured hippocampal neurons: molecular and functional variants by RNA editing. Neuron 14:1009-1017 (1995).